Dopaminylation: looking at Parkinson’s from a new angle
Winnie Chen (left) is an MD PhD student in the lab of Ian Maze at Mount Sinai (NY, USA). Winnie’s current work is focused on understanding the role of dopamine in Parkinson's disease. The lab is interested in the new idea that dopamine can act as a post-translational modification of proteins. In this interview from the meeting of the Society for Neuroscience (SfN), Neuroscience 2024 (5–9 October; Chicago, IL, USA), Winnie discusses a project that uses a novel chemical probe to investigate the dopaminylation of proteins, particularly histone H3, in Parkinson’s disease and aging. What are you presenting at SfN?...
To view this content, please register now for access
Join our member community for FREE to access a collection of journal and online-only features, including:
- Exclusive access to educational videos, eBooks and insights into top BioTechniques journal articles
- The latest news and journal updates delivered straight to your inbox when you want it
- Personalized recommendations for the latest member-exclusive podcasts, interviews and expert opinions
- Priority registration to webinars, panel discussions and events
- Access to competitions and journal publication discounts, including 10% off open access fees when you sign up today!
